The Current Ratio as of December 2025 (TTM) for Handa Pharmaceuticals, Inc. (6620.TWO) is 32.44

According to Handa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 32.44. This represents a change of 118.04% compared to the average of 14.88 of the last 4 quarters.

Handa Pharmaceuticals, Inc. (6620.TWO) Historical Current Ratio (quarterly & annually)

How has 6620.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Handa Pharmaceuticals, Inc. over the last ten years is 9.35. The current 32.44 Current Ratio has changed 34.58% with respect to the historical average. Over the past ten years (40 quarters), 6620.TWO's Current Ratio was at its highest in in the September 2023 quarter at 45.50. The Current Ratio was at its lowest in in the March 2024 quarter at 7.30.

Handa Pharmaceuticals, Inc. (6620.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Handa Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Handa Pharmaceuticals, Inc. (6620.TWO) Average Current Ratio

How has 6620.TWO Current Ratio performed in the past?

The current Current Ratio of Handa Pharmaceuticals, Inc. (6620.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Handa Pharmaceuticals, Inc. (6620.TWO) Current Ratio vs. Peers

How is 6620.TWO’s Current Ratio compared to its peers?

Handa Pharmaceuticals, Inc.’s Current Ratio is greater than Grape King Bio Ltd (1.80), greater than TTY Biopharm Company Limited (1.77), greater than Synmosa Biopharma Corporation (2.45), greater than Alar Pharmaceuticals Inc. (26.49), greater than YungShin Global Holding Corporation (3.66), greater than ScinoPharm Taiwan, Ltd. (7.85), greater than Sunmax Biotechnology Co., Ltd. (3.85), greater than Great Tree Pharmacy Co., Ltd. (1.59), greater than TaiMed Biologics Inc. (18.84), greater than EirGenix Inc. (7.56),

Build a custom stock screener for Handa Pharmaceuticals, Inc. (6620.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Handa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Handa Pharmaceuticals, Inc. (6620.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Handa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.